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1. Introduction 
Theodosius Dobzhansky (1973) proclaimed, “Nothing in biology makes sense except in the 
light of evolution.” But how can evolution make sense of something as manifestly 
maladaptive as metastatic tumors, leukemia, and lymphomas? How does evolution explain 
cancers invading and destroying vital tissues? How are “[u]ncontrolled cell proliferation” 
(Sherr, 1996) and “[g]enetic lesions that disable key regulators” (Sherr, 2000) reconciled with 
evolution?  
Possibly cancers appeared unbidden in vertebrates without having evolved! This possibility 
cannot be dismissed out of hand, since animals on invertebrate branches of the metazoan 
tree, Lophotrochozoa, Ecdysozoa, bilaterians, coelomates, and deuterostomes develop non-
malignant growths spontaneously but not cancers (Sutherland, 1969; Matz, 1969).  
On the other hand, induced malignancies in Drosophila (Gateff & Schneiderman, 1969), 
“[a]lthough not naturally occurring” (Gonzalez, 2007), and aberrant patterns of cell death 
and changes in specification in Caenorhabditis elegans suggest that cryptic cancers exist in 
invertebrates. Moreover, widely distributed molecular homologues (i.e., genomic equivalents) 
in metazoans point to fundamentally “conserved” or “canonical, core pathways” common 
to human cancers and invertebrate tissues (Potts & Cameron, 2011). For example, “ancestral 
forms of myc and max [onco]genes … [appear in] the early diploblastic cnidarian Hydra“ 
(Hartl et al., 2010), and a portion of an acute myelogenous leukemia gene (AML1) has 67% 
identity over 387 base pairs with 69% amino acid identity with the Drosophila segmentation 
gene runt (Erickson et al., 1992). In addition, cell death is induced by genotoxic stress in 
Drosophila as it is in cancers (Jin et al., 2000). 
Other molecular evidence also supports the notion of cancer’s evolution. For instance, 
evolutionary creativity, competition, and selection are suggested by redundancy of the 
human p53 cancer suppressor gene known as the “guardian of the genome” (Levine & Oren, 
2009). Moreover, the planarian homologue of human p53 “functions in stem cell 
proliferation control and self-renewal” (Pearson & Alvarado, 2010); “ancestral forms” of p53 
“mediate … multiple stress responses in the soma” of C. elegans; and “a primordial p53 
ancestor gene which appeared early in phylogenesis” is found in the squid, Loligo forbesi 
(Schmale & Bamberger, 1997). 
More direct evidence for cancers in invertebrates has emerged from efforts to evaluate 
effects of pollutants on animals. For example, a transmissible sarcoma that breaks out 
epizootically in Maryland soft-shell clams, Mya arenaria, would seem to be infectious but 
may also be synergistically promoted by contamination with the pesticide chlordane (Farley 
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et al., 1991). Herbicide contamination is also correlated with outbreaks of gonadal 
neoplasms (seminomas and dysgerminomas) and catastrophic declines of reproduction in 
softshells (Gardner et al., 1991a) and in hard shell clams (Mercenaria spp.) (van Beneden, 
1994). Similarly, the eastern oyster, Crassostrea virginica, develops neoplasm at multiple sites 
when exposed to suspensions of Black Rock Harbor sediments known to contain “genotoxic 
carcinogens, co-carcinogens, and tumor promoters.” And winter flounders fed on the blue 
mussel, Mytilius edulis, raised on contaminated sediments develop renal and pancreatic 
neoplasm “demonstrating trophic transfer … up the food chain” (Gardner et al., 1991b). The 
carcinogens in polluted effluvia, such as polynuclear aromatic hydrocarbons, chlorinated 
hydrocarbons, pesticides, and/or metals sequestered by aquatic bivalves induce liver 
neoplasm in teleosts and in human beings (Stegeman & Lech, 1991).  
Animals, larvae, and embryos also play tricks on cancers that seem rooted in an 
evolutionary past. For example, an aqueous extract from the common clam (Mercernaria 
mercenaria) promotes regression in viral induced tumors in hamsters and melanomas in mice 
(Li et al., 1972). The soft coral, Sarcophyton glaucum, produces an anti-tumor agent effective 
against the development of chemically induced mouse skin and rat colon carcinoma 
(Narisawa et al., 1989). And receptors for the snail hemagglutinin HP present “on leukaemic 
lymphocytes … in combination with conventional surface marker analysis provides a new 
important tool for monitoring patients with CLL [chronic lymphocytic leukemia]” 
(Hellström et al., 1976).  
Another argument in favor of cancers’ evolution relies on reminiscences of recapitulation, 
namely that presumptive ancestral types of animals and younger human beings foster fewer 
malignancies than adult human beings. For instance, in Drosophila, “metastases nearly 
always occur in transplanted [adult] hosts rather than in the larva in which the primary 
tumours first arose” (Gonzalez, 2007). In human beings, the “overall incidence of cancer in 
persons under 15 years of age is one-thirtieth that of the population as a whole … Indeed, 
most pediatric cancers consist of leukemias, lymphomas, and sarcomas … In contrast, more 
than 80% of adult cancers in the United States are carcinomas … and 8% are hematopoietic 
with a higher preponderance of myeloid leukemia than is observed in children … 
Carcinomas are rare in persons under age 30, rising exponentially in incidence thereafter” 
(Sherr, 1996).  
Rather than never having had cancers, invertebrates and human young seem to have 
evolved successful strategies of cancer suppression, at least before anthropogenic pollution 
lowered the bar to tumorigenicity. Conceivably, in human beings, inclusive fitness (the sum 
of advantages that project a living thing’s progeny into the next generation) pushed cancers 
generally and carcinomas and myelomas in particular into adult years beyond the 
reproductive prime.  
On balance, evidence of cancers having evolved is abundant and robust. If Dobzhansky is 
right, therefore, the light of evolution will yet illuminate the biology of cancers (Shostak, 
1981, 2007-8; Zimmer, 2007).  
2. Studying cancers’ evolution 
In order to avoid ambiguity, the sense in which the “evolution of cancer” is used here must 
be distinguished from the sense in which the “evolution of cancer” is typically used in the 
oncology literature. Oncologists typically equate “cancer’s evolution” with “tissue 
independent [gene-expression] signature[s] associated with metastasis” (Ramaswamy et al., 
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2003; van ‘t Veer et al., 2002) or mutational patterns (aka spectra) appearing throughout a 
cancer’s development from a single cell. The “cancer genome … [is said to leave] an 
archaeological record bearing the imprint of [mutagenic and DNA repair] processes” 
(Stratton, 2011).  
This developmental/genetics’ sense of “cancer’s evolution” is not the sense in which the 
term is used here. Here, “cancers’ evolution” refers to cancers’ proterozoic origins and 
subsequent history of adaptations leading to contemporary malignancies.  
Phylogenomic analysis would be the method of choice for studying cancers’ evolution in the 
sense intended here, and, no doubt, such an analysis will be feasible when “[o]ver the next 5 
to 7 years … tens of thousands of cancer genomes will be sequenced … an essentially 
complete set of cancer genes … revealed … [and] the complete catalog of somatic mutations 
provided by the sequence of the cancer genome” (Stratton, 2011). Today, however, cancer’s 
phylogenomics are inaccessible. Rather, spotty spectra of mutations all but obliterate the 
trail of cancers’ genomic phylogeny. Instead of genomic coherence, clonal diversity in 
cancers is found in copy number DNA profiling (Notta et al., 2011) and multiplexing 
fluorescence in situ hybridization (Anderson et al., 2011). The results of single-nucleus 
sequencing in two ductal human breast cancers and paired liver carcinomas show that 
“metastatic cells arise late in tumour development” and that tumors grow by “punctuated 
clonal evolution” with few persistent intermediates (Navin et al., 2011). Making matters 
worse, rather than translocations at oncogenic sites producing cancers (Bohr et al., 1987; 
Croce, 2008), single catastrophic events lead to massive chromosomal rearrangements, and 
chaotic chromosomal architecture (Stephens et al., 2011; Berger et al., 2011; Tubio & Estivill, 
2011). Furthermore, outside the cellular mainstream, “cancer can be initiated in cells … 
[with] long-term reconstituting ability … [and] self-renewal capacity” (Visvader, 2011); 
metastases may be formed where malignant niches recruit cells from local or circulating 
sources (König et al., 2005); and tumors may arise from long dormant cancer initiating cells 
(CICs) “with a metastatic potential … [to] disseminate … even at a premalignant stage” 
(Ansieau et al., 2008). Ultimately, “it is unclear how best to assess the effects of new genetic 
lesions on … growth, differentiation, tumorigenicity and functionality” (Pera, 2011). 
Cancers’ evolution is thus pursued here the old-fashioned way, by following Charles 
Darwin’s lead and asking, “[without supposing] that the modifications were all 
simultaneous … [how would d]ifferent kinds of modification … serve the same general 
purpose” (Darwin, 1958 [1872])? In the case of cancer, the notion of a “general purpose” is 
epitomized by cancers’ stem cells invading normal tissues and destroying their cells while 
metastasizing, and, growing elsewhere in the organism to the same effect. Darwin’s 
question becomes, therefore, what “kinds of modification” would produce cancers’ stem 
cells?  
Two distinctly different possible answers stand out: (1) Cancers’ stem cells arose from 
normal self-renewing cells which added invasiveness, destructiveness, and metastasis to 
their repertoire of cell behaviors; (2) Cancers’ stem cells and normal tissues’ stem cells arose 
through competition within cell populations in response to evolutionary pressures and 
adaptive advantages. 
3. Is the stem cell the root of cancers’ evolution? 
Did a rudimentary stem cell provide the ancestral branch or common root of cancers’ stem 
cells? The cancer stem cell theory encapsulates this idea by proposing that normal tissues 
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and cancers converge on stem cells. The problem is to find common ground among the 
many cells identified as both normal and cancer stem cells.  
In general, stem cells fall into three or four categories: adult stem cells, separated into organ 
stem cells (OSC aka somatic stem cells) and hematopoietic stem cells (HSC), germ stem cells 
(GSC), and embryonic stem cells (ESC). Each of these has its malignant complement: cancer 
stem cells (CSCs) in solid tumors complement OSCs in solid organs; malignant HSCs 
(malHSCs) in leukemia, lymphoma, and related cancers represent the malignant counterpart 
of HSCs of normal blood and lymph; malignant GSCs (malGSCs) in testicular and ovarian 
cancer are the malignant counterparts of oogonia and spermatogonia; malignant embryonic 
stem cells (malESCs), thought to be present in small cell cancers and other malignancies, 
resemble (hypothetical) retained or reproduced post-embryonic ESCs.  
The list is easily expanded by adding other cells called stem cells (see below), but the list is 
also contracted by squeezing one or another so-called stem cell into the above categories. 
For example, mesenchymal stem cells (MSCs) resemble HSCs or marrow stem cells (also 
MSCs) in several ways including differentiating as skeletal muscle, fat, cartilage, or bone 
(Young et al., 2004). Even GSCs are easily absorbed in the HSC category, inasmuch as both 
types of stem cells are derived embryonically from wandering, infiltrating, and colonizing 
cells (see Shostak, 1991), and both are especially plastic in the range of cells ultimately 
differentiating from their stock.  
The most problematic stem cells are the ESCs. Whether they exist in adults at all is 
uncertain, although OSCs and HSCs are sometimes said to be virtual ESCs. This claim 
would seem vastly exaggerated, since neither OSCs nor HSCs possess ESCs’ prime virtue of 
differentiating into cells of all three germ layers. Rather, ESCs are subsumed by germ layers 
in early development and disappear entirely in the parenchyma and stroma of adult organs 
during morphogenesis. OSCs and HSCs then emerge fresh in adult tissues. 
Some similarities between the behavior of embryonic and cancer cells suggested that cancers 
originated from leftover or restored embryonic cells, but, historically, the alternative idea 
that stem cells produced metastases took precedence. This idea is traced to Rudolf Virchow. 
Even if he didn’t use the term, he clearly attributed metastasis to unique proliferative cells as 
distinguished from differentiated cells. He wrote, “the transference … disposes different 
parts to a reproduction of a mass of the same nature as the one which originally existed,” 
although, later, he added that he “must confess” that he can do no more than “allow it to be 
possible that the diffusion by means of vessels may depend upon a dissemination of cells 
from the tumours themselves” (Virchow, 1971 [1863]).  
Evidence of stem cells as a source of cancer was indecisive until it became overwhelming: 
injected single murine embryonal carcinoma cells (ECCs) produced teratocarcinomas 
(Kleinsmith & Pierce, 1964); cells of a non-T cell line produced human acute lymphoblastic 
leukemia (ALL) (Kamel-Reid et al., 1989); “primitive hematopoietic cells” as opposed to 
“committed progenitors” produced human acute myelogenous leukaemia (AML) (Lapidot 
et al., 1994; Bonnet & Dick, 1997); small “CD44+CD24-/low Lineage- [cell] populations” 
uniquely formed breast cancers (Al-Hajj et al., 2003), and as few as one hundred CD133 
positive cells from human brain cancers recreated “classical histopathological features of 
[the patient’s original] tumour type” in immuno-compromised mice (Singh et al., 2004). The 
idea of “a small subpopulation of leukemic stem cells that possess extensive proliferative 
capacity and the potential for self-renewal” was quickly generalized to a cancer stem cell 
theory according to which cancers were stem cell-supported and metastases were stem cell-
dependent (see Lobo et al., 2007).  
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Cancer stem cell theory’s great attraction was the explanation it offered for two of 
malignancy’s great enigmas, namely, recurrence and the enhanced resistance to chemo- and 
radiation therapy displayed by the returning cancer (O’Brien et al., 2007–8; Gilbert & Ross, 
2009; Ropolo et al., 2009). The explanation was seductively simple: Chemo- and 
radiotherapies targeted the abundant, rapidly dividing non-stem cancer cells, while rare 
stem cells dividing at low rates escaped the effects of treatment and regenerated the cancer. 
Moreover, since selection for a predisposition to resistance was also in play, the recurrent 
cancers had enhanced resistance to similar therapies. The prognostic and therapeutic 
implications were unmistakable: the fewer stem cells, the more promising the prognosis; 
eradicating a cancer depended on eliminating all stem cells.  
Cancer stem cell theory soon launched a virtual cancer stem cell industry. Its business was 
to define, find, and isolate cancer stem cells for the purpose of destroying them.  
3.1 Defining stem cells  
Stem cells’ principal attribute is self-renewal, the ability to maintain or expand a specific 
population of stem cells through cell division while also producing cells that give rise to a 
tissue’s or a cancer’s bulk (characteristic) cells. Self-renewal takes place in either a 
maintenance or expanding mode. In normal adult tissues at homeostasis, OSCs, HSCs, 
GSCs, and possibly ESCs undergo maintenance self-renewal by dividing asymmetrically 
thereby giving rise to different sibling cells (Chartier et al., 2010). Generally, one cell replaces 
the stem cell and one enters a “transit amplifying” (TA) pathway of division, terminal 
differentiation, and disposal. CSCs, malHSCs, malGSCs, and malESCs also perform 
asymmetric division, producing stem and bulk tumor cells, (Norton, 2007-8; Powell et al., 
2010; Quyn et al., 2010), but following a premalignant transition and in growing cancers 
some stem cells also undergo expanding self-renewal by symmetric division (Tomasetti & 
Levy, 2010) thereby giving rise to identical self-renewing sibling cells, enlarging the cancer 
stem cell population and contributing to tumorigenesis.  
The difference in the mode of self-renewal places cancer and normal stem cells on a sliding 
scale rather than separate stem cell branches. Some other differences between normal and 
cancer cells are also differences of degree rather than kind. For example, ECCs produce 
benign cells and normal tissues within teratocarcinomas (Pierce, 1974) and differentiate into 
normal mammary epithelium in epithelial-free mammary fat pads of athymic (aka nude) 
mice when mixed with mouse mammary epithelial cells (Bussard et al., 2010a).  
But defining stem cells by self-renewal may still not homogenize them. According to the 
“gold standard assay” (Clarke et al., 2006), putative stem cells renew themselves while 
giving rise to tumors following transplantation in vivo and to tumor-like nodules following 
serial passage in vitro. The assay breaks down, however, for identifying stem cells that resist 
transplantation and nodule formation.  
A different assay identifies stem cells without recourse to transplantation or passage. This 
assay relies on the retention of label by cells in long-term pulse-chase experiments and the 
premise that stem cells divide rarely. For example, putative smooth muscle stem cells of the 
uterine myometrium are labeled in perpetuity by a pulse with the DNA nucleotide-mimic  
5-bromo-2–deoxyuridine (Szotek et al., 2007). These “label-retaining cells” (LRCs) are also 
found in the endometrial epithelium and stroma (Chan & Gargett, 2006), intestinal 
absorptive and gland epithelium, mucous epithelium of the tongue (Fellous et al., 2009), 
mammary epithelium (Booth et al., 2008), neurons (Das et al., 2003), satellite reserve skeletal 
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muscle cells (Shinin et al., 2006; Conboy, Karasov, & Rando, 2007; Kuang et al. 2009), and in 
cancers of the breast (Trosko, 2006; Bussard et al., 2010b) and intestine (Barker et al., 2008). 
LRCs are also found in yeast (Klar, 1987), bacteria, plants, fungi, the round worm, 
Caenorhabditis elegans, the fruit fly, Drosophila, and elsewhere (Tajbakhsh et al., 2009).  
A sluggish division rate might represent an anti-mutation adaptation since delaying cell 
division provides an opportunity for correcting replication errors and performing DNA 
repair. Thus, in cancers’ stem cells, the post- and pre-mitotic gaps (see below) function as 
checkpoints for DNA damage and damage response signaling networks (Bao et al., 2006; 
Kuntz & O’Connell, 2009). Lengthening these gaps and suspending progress through the 
cycle, therefore, would aid in repairing damaged DNA (Wang et al., 2009). On the other 
hand, cells with damage too severe to be adequately repaired are dispensed without 
replicating their errors. 
But if the LRC divided repeatedly after acquiring the labeled DNA precursor, the cell might 
have remained labeled because it retained labeled “immortal strands” of DNA while casting 
off unlabeled DNA strands replicated during the chase phase of the experiment (Cairns, 
2006). The retention of “immortal strands” of DNA would also seem an anti-mutation 
adaptation, since it would help keep stem-cell DNA pristine by reducing opportunities for 
errant base substitution during replication (Cairns, 2006; Seaberg & van der Kooy, 2003; but 
see Sotiropoulou et al., 2008). “Immortal strand” retention may “apply to only a subset of 
stem cell lineages” (Neumüller & Knoblich, 2009), and epigenetic changes, such as an 
increase of methylation, may accumulate in “immortal strands” thereby compromising the 
efficacy of this “anti-mutation” adaptation (Genereux, 2009). But asymmetric division is a 
decidedly regulated process in some stem cells where it occurs, for example, in the GSCs of 
male Drosophila where the older “centriole is always in the centrosome that is … retained by 
the stem cell” (Gonzales, 2007). Hence, retaining “immortal strands” is not a mere 
coincidence and is presumably adapted to some function such as mutation prevention. 
3.2 Finding and isolating stem cells  
Putative stem cells are found by in situ hybridization with antibodies for specific antigens. 
For example, antigens for Lgr5 gene products label LRCs in intestinal glands and hair 
follicles (Bussard et al., 2010b). Some markers are associated predominantly with malignant 
stem cells. For example, human breast cancer cells are CD44+CD24-/low (Al-Hajj et al., 2003), 
leukemic stem cells (LSCs) are CD34 positive CD38 negative (Bonnet & Dick, 1997), and 
colon cancer (O’Brien et al., 2007; Ricci-Vitiani et al., 2007) and human glioma cells are 
CD133 positive (Singh et al., 2004). Other markers change with malignant progression. For 
example, the “CD133+, epithelial-specific antigen-positive … population is increased in 
primary non-small cell lung cancer (NSCLC) compared with normal lung tissue and has 
higher tumorigenic potential in SCID mice and expression of genes involved in stemness, 
adhesion, motility, and drug efflux than the CD133− counterpart” (Bertolini et al., 2009). But 
problems arise over the antigen detected, the antibody used, the specificity of the 
antigen/antibody complex (see Lobo et al., 2007; Rao et al., 2010), and how closely tied the 
antigen is to a self-renewal signal pathway (Barker & Clevers, 2007).  
Happily, some techniques accommodate multiple criteria allowing for “cross checking.” 
Conspicuously, cytometric cell sorting allows researchers to combine multiple criteria for 
stem cells while providing living cells for further experimentation. With the help of 
fluorescence-activated cell sorting (FACS; Watt, 1998; Osborne, 2010), researchers can isolate 
presumptive OSCs, HSCs, CSCs, malHSCs, and putative malESCs in a “side population” 
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(SP) of cells able to reduce their load of supravitally absorbed dye (i.e., they exhibit Hoechst 
33342 or Rhodamine 123 “effluxing”). Much like chemotherapeutic reagents, incorporated 
Hoechst 33342 and Rhodamine 123 are pumped out of (i.e., “effluxed” from) presumptive 
stem cells via the action of transporters (i.e., members of the ABC transmembrane protein 
family such as the ABCG2 transporter pump in mice) said to be uniquely over expressed in 
stem cells and embedded in their boundary lamella. Thus, presumptive stem cells have been 
isolated in SP fractions of cells from a host of normal organs, tissues, and cell populations: 
bone and dental tissues, cardiovascular tissue, endometrium (lining the uterus), endothelia 
(lining blood vessels), epidermis, gastrointestinal epithelium, mammary gland, neural 
tissue, pituitary and thyroid glands, and elsewhere (Welm et al., 2003; see Telford, 2010). 
And some SP cells originating from cancers also pass the “gold standard assay” and form 
tumor-like nodules in minimum, low adhesion medium, while they produce histologically 
recognizable tumors in histo-compatible mouse strains such as immuno-incompetent nude 
mice, immuno-compromised non-obese diabetic (NOD), severe combined immunodeficient 
(SCID) mice, combined NOD/SCID mice, and more severely genetically compromised 
NOD/SCID mice. These SP cells also carry stem cell-relevant antigens and cell markers, for 
example, antigens associated with high plasticity (Sox2 and Oct4, but see Lengner et al., 
2007), embryonic activities (stage-specific embryonic antigens [SSEA], Nanog, Sox4, Isl-1, 
and Pax6; see Konala et al., 2010), and specific histotypic markers (pituitary specific factor 
[Prop1]) alone and in combination (Garcia-Lavandeira et al., 2009).  
A problem arises, however, about the size of a transplantable stem cell population identified 
operationally in the SP fraction. When does size exceed reasonable expectations for “a small 
subpopulation” conforming to traditional expectations for stem cells? Consider, for 
example, a “tumorigenic subpopulation with [melanoma] stem cell properties enriched in a 
CD20+ [SP] fraction [that] produces tumor-like non-adherent spheroids in culture with the 
plasticity of neural crest stem cells and a capacity for self-renewal” (Fang et al., 2005). A 
small percentage (<0.1%) of these cells are transplantable in NOD/SCID mice, but as much 
as 20% of “melanoma tumor stem cells” (MTSCs) positive for neural growth factor receptor 
CD271 (Boiko et al., 2010) give rise to tumors in more highly immune-compromised mice 
(i.e., NOD/SCID mice lacking the interleukin-2 gamma receptor, i.e., natural-killer cell 
activity; Quintana et al., 2008). This high percentage of melanoma cells able to transfer the 
tumor to these mice “suggests that either virtually every melanoma cell is a CSC because it 
can induce de novo tumors in xenograft assays irrespective of any known stem cell marker, 
or that melanoma is not hierarchically organized into subpopulations of tumorigenic and 
nontumorigenic cells and the CSC model does not apply” (Roesch et al., 2010).  
3.3 Normal and malignant stem cells: Comparisons and contrasts  
Stem cells sit on top of differentiation pyramids of cells (Reya et al. 2001). Hence, inevitable 
similarities appear in normal and malignant stem cells. “Indeed, in several tissues, normal 
stem cells and cancer stem cells (CSCs) have been identified using the same set of markers” 
(Dey & Rangaragan, 2010). For example, paired antigens are found in lung parenchyma and 
malignant adenocarcinoma of the lung (Kim et al., 2005) and in pancreatic acinar and 
pancreatic cancer cells (Hermann et al., 2007).  
Some similarities are readily attributed to routine functions performed by normal and 
malignant cells. For example, cells of both types undergo mitotic cycling, periodically going 
through mitosis (M [chromosomal events prior to and accompanying cell division]) 
followed by a post-mitotic gap (G1), a period of DNA synthesis (S), and a pre-mitotic gap 
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(G2). And some similarities may be superficial (i.e., analogies instead of homologies). 
Conspicuously, “self-renewal” in stem cells may be a consequence of “transformation” or 
immortalization (Shay et al., 2001). Immortalized normal cells even become tumorigenic 
when introduced in immuno-compromised mice. For example, human B-lymphoblastoid 
cell lines immortalized by the Epstein-Barr virus become cancer-like in several ways: 
expressing telomerase (the ribonucleoprotein that elongates telomeres), exhibiting 
aneuploidy (an abnormal number of chromosomes), sustaining mutations in the cancer 
suppressing p53 gene, and failing to undergo apoptosis (Sugimoto et al., 2004). And 
immortalization is effected by a variety of devices that may be irrelevant to oncogenesis or 
over-determined: fusion with cancer cells, treatment with carcinogens, transfection with 
particular oncogenes such as myc, activation of normal cellular proto-oncogenes, 
transformation with Epstein-Barr virus, retrovirus-mediated oncogene transduction, human 
T-cell leukemia virus type 1 (HTLV-1) and simian virus 40 large T-antigen oncogene, human 
papillomavirus, etc.  
On the other hand, some difference may be rationalized with the help of reasonable 
argument. For example, the difference between symmetric and asymmetric division may be 
reconciled if division in stem cells is facultative rather than constitutive and if the same cells 
that contribute to homeostasis via asymmetric division can support growth via symmetric 
division (Morrison & Kimble, 2006). In male rats, for example, differences in the mode of 
division depend on conditions. Large cells with outer membranes rippling with amoeba-like 
pseudopods (as opposed to cells with a smooth outline) are committed GSCs (aka 
gonocytes) that perform both asymmetric and symmetric division. Although male GSCs 
maintain a steady state population as spermatogonia in adults, the cells proliferate 
symmetrically and generate spermatogenic colonies when transplanted to infertile testes 
(Orwig et al., 2002). Thus, at least some stem cells would seem able to divide both 
asymmetrically and symmetrically.  
Greater difficulty is encountered rationalizing differences in label-retaining cells (LRCs), 
namely, their presence among OSCs and CSCs versus their absence in HSCs and malHSCs 
(but see Wilson & Trumpp, 2006). Caveats aside, if HSCs and malHSCs are not LRCs, they 
cannot differentially segregate new and “immortal strands” of DNA during asymmetric 
division (Kiel et al., 2007). And other differences cannot be ignored. For example, while 
OSCs and (most) CSCs are confined to niches, HSCs and malHSCs circulate in peripheral 
blood (and umbilical blood, in the case of the fetus and newborn). Furthermore, unlike 
products of OSCs and CSCs, products of HSCs and malHSCs, and their dormant memory 
cells (see below) may regain self-renewal. 
HSCs also exhibit far greater potential than OSCs and give rise to clones of hematopoietic 
proliferative precursors or progenitors (HPPs) with greater competences than transit-
amplifying cells (TACs) produced by OSCs. In vivo, bone marrow derived HSCs known as 
stromal cells have a reputation for extraordinary “transmutation” to nerve and other non-
hematopoietic cells, even if, in vitro, their range of transformations narrows to osteoblasts, 
chondrocytes, adipocytes, and possibly myoblasts (Prockop, 1997). Consequently, HSCs 
were once thought to be available for extensive “reprogramming” and multilineage 
differentiation compared to other stem cells. Prior to 2006 when induced pluri-potential 
stem cells (iPSCs) came along, HSCs were supposed to be the great hope of regenerative 
medicine (Trounson, 2009).  
Reprogrammability is not open ended, however, and early hopes for HSCs’ did not pan out 
despite their vast multi-potentiality. HSCs failed to exhibit pluripotency (the ability to 
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differentiate into tissues formed by all germ layers) when injected into blastocysts (Geiger et 
al., 1998) and failed to differentiate as cardiac myocytes when injected into damaged hearts 
(Murry et al., 2004). Some claims for HSCs’ multipotency may have been exaggerated as a 
consequence of fusion with differentiated cells (Terada et al., 2002; Ying et al., 2002; Wagers 
& Weissman, 2004). The ability to fuse may be an interesting characteristic of HSCs and 
HPPs, but it is not especially promising as a method in regenerative medicine. Ultimately, 
instead of progress toward applications in regenerative medicine, “confusion looks set to 
continue” (Check, 2007). 
In addition, significant differences abound among post-stem cell (non-self renewing) 
products in normal tissues and cancers. TACs and HPPs both divide symmetrically 
producing clones of bulk cells committed to determined pathways of terminal 
differentiation and disposal, but HPPs have vastly greater competences for differentiation 
than TACs. The products of CSCs and malHSCs also differ in their plasticity, with malHSCs 
sometimes called “primitive HSCs” because of the greater range of malignant phenotypes 
available to them. 
Typically, the malignant phenotype “progresses” from dividing and invading cells 
destroying tissue locally to metastasizing cells repeating these processes at new sites. In the 
process, CSCs produce cancer transit amplifying cells (CTACs). The CTACs of less 
malignant cancers, such as teratocarcinomas, undergo terminal differentiation in any of a 
variety of directions. More generally, the “difference between cancer and normal tissue 
renewal is that in normal tissue renewal, the number of cells that are proliferating is 
essentially equal to the number of cells terminally differentiating (undergoing apoptosis), 
whereas in cancer the number of cells that are proliferating ([cancer] transit-amplifying 
cells) is greater than the number of cells that are entering terminal differentiation, because of 
maturation arrest of the cancer cells in the transit amplifying population” (Sell, 2008). In 
more malignant carcinomas, CSCs or CTACs pass through an epithelial-to-mesenchymal 
transition (EMT), become motile, and all the more malignant and metastatic (Prindull & 
Zipori, 2004). Likewise, malHSCs produce malignant HPPs (malHPPs) that not only display 
the malignant phenotype but are recruited to metastastatic sites from circulation. MalHPPs 
have also been accused of re-acquiring self-renewal with its consequent resistance to 
radiation and chemotherapy (Lapidot et al., 1994).  
Disposal also takes place through different mechanisms in the products of different stem 
cells. In cellular apoptosis or caspase-dependent cell fragmentation, cell fragments known as 
apoptotic bodies are ingested and digested by neighboring cells (known as entosis) leaving 
healthy tissue behind. In tissue disposal or caspase-independent programmed cell death, 
aka autophagy, cytokines attract leukocytes and immune cells inducing an inflamed 
response and mass destruction. Other cellular disposal methods include phagocytosis by 
macrophages in localized centers (e.g., spleen, thymus) of effete cells marked by 
components of the complement and/or immune system, and the shedding of mature cells at 
topographically external surfaces.  
Unlike normally produced TACs and HPPs, AMLs produce massive numbers of malHPPs 
that die before differentiating (Bonnet and Dick, 1997). In contrast, CTACs may have 
prolonged lifetimes as a consequence of delayed programmed cell death. “When baseline 
levels of autophagy are compared with many cancer cells and noncancerous cells from the 
same tissue, decreased autophagy is observed in many cancer cells … [C]ells within the 
center of the tumor, deprived of an adequate blood supply have upregulated autophagic 
flux to allow for survival in the hypoxic and low nutrient microenvironment … Many cancer 
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therapies considered over the last couple of years have been thus paradoxically aimed at 
either inducing or reducing levels of autophagy” (Demaria et al., 2010). 
In sum, the closer one looks the harder it seems to harmonize stem cells. Even bona fide stem 
cells do not fall comfortably into a single category. Stem cells cannot be present in small and 
large numbers, divide infrequently and frequently, be both long-lived and short-lived and 
both capable of retaining “immortal strands” of DNA and not. Oncologists, like other 
scientists suffer from the tendency to lump phenomena together and to over-generalize, but 
lumping cells together under the “stem” umbrella does not illuminate the mysteries of 
cancer. Thus, the possibility of tracing cancers’ stem cells’ origins to a rudimentary stem cell 
must be abandoned and the search begin again elsewhere. 
4. Are cell populations the roots of cancers’ evolution? 
Did cancers’ stem cells evolve through mutual competition and selection in cell 
populations? The problem answering this question is that little is known about cell 
populations and virtually nothing about their evolution.  
Cell populations are groups of cells sharing developmental and morphological 
characteristics. Cell populations are the constituents of tissues (i.e., epithelia, connective, 
blood and lymphatic, muscle, and nerve tissue), of parenchyma (i.e., major, conspicuous or 
characteristic cell type), and stroma (i.e., supporting the parenchyma) of organs (Baker, 1988; 
Hughes, 1989; Harris, 1999). Initially, “cell populations constituting multicellular organisms 
… [were] roughly classified, based on their kinetics, into three main groups,” static, transit, 
and stem (Lajtha, 1979). This classification required amendment, since “transit” cells were 
derived from stem cells and did not, therefore, constitute a unique class, and other cell 
populations were not static, transit, or stem (e.g., the endothelium of vessels).  
Table 1 is a new taxonomy for animal cell populations at homeostasis based on three 
dichotomous descending divisions: (1) Classes of attached or epithelial-like cell populations 
versus unattached or amoeba-like cell populations, (2) subclasses of steady state versus 
static cell populations, and (3) subsets of stem versus non-stem cell populations. Both stem 
and non-stem populations are found in three of the four subclasses, the exception being the 
attached, static state subclass containing only stem-like (reserve) cell populations. In 
addition, the subset of unattached, static, non-stem cell populations is partitioned into cell 
populations with stress-induced and developmentally produced dormancies. 
4.1 Classes, subclasses and subsets of cell populations 
Attached or epithelial-like cells are mounted on an extracellular membrane (e.g., the basal 
lamella of the epidermis) and share intimate contacts with each other in the form of 
intercellular and gap junctions or synaptic junctions. Nuclei are typically enclosed in a 
cytoplasm limited by a plasmalemma, but cells may also fuse in syncytia containing 
multiple (nondividing) nuclei. Cells in attached populations have limited plasticity or range 
of differentiation. Mono-potent cells differentiate into only one type of cell, and oligo-potent 
cells differentiate into a few related types of cells. 
In contrast, unattached or amoeba-like cells are embedded or suspended in extracellular 
material and do not have intimate contacts with each other. Amoeba-like cells may have 
intercellular bridges (sex cells; see Shostak 1991) or be fused in plasmodia (Physarum) with 
mitotically active nuclei (as distinct from syncytia). Unattached amoeba-like cells also tend 
to be oligo-potent or multi-potent, having competence to differentiate into more than one 
cell type epitomized by germ cells.  
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Steady state cell populations produce as many cells by cell division as they lose through 
terminal differentiation and cell disposal. In contrast, static state cell populations do not 
produce new cells and lose cells primarily as a result of wear-and-tear, trauma, and aging. 
Stem cell-supported populations are hierarchal containing different types of dividing cells, 
some of which (i.e., stem cells) are self-renewing and also give rise to clones of terminally 
differentiating cells. The populations may cycle at a constant rate, and be homogeneous, or 
they may cycle at different rates, move out of phase, and be heterogeneous.  
In contrast, non-stem cell populations are non-hierarchal containing uniformly dormant 
cells or more or less identical cells that are both dividing and differentiated. Cells divide 
symmetrically in or out of phase. They are non-hierarchal, since they are more or less 
uniformly differentiated, although differentiation may proceed stochastically, regressively, 
or progressively across spatial and physiological gradients. 
 
4.2 Specific categories of somatic cell populations  
All adult somatic cell populations fall into eight categories (Table 1): (1) cache cells (CCs), (2) 
organ stem cells (OSCs), (3) reserve cells, (4) neoblasts, (5) stressed cells, (6) quiescent cells, 
(7) hematopoietic stem cells (HSCs), and (8) mesenchyme. Cache cells and neoblasts are 
primitive cells in the attached (epithelial) and unattached (amoeboid) categories, 
respectively. Other normal cells in these classes represent derived cells including germ cells 
placed in the HSC category. Neoplasm occurs and cancers develop in all but two of the 
categories, namely 4 and 5.  
The origin of germ stem cells (GSCs) from amoeboid, neoblasts, and interstitial cells in 
invertebrates, and conspicuously from wandering cells in vertebrates relegates GSCs to the 
unattached cell line and places them in the HSC category. The amoeboid spermatozoon of 
nematodes makes the case plainly, and, like vertebrates’ HSCs, embryonic GSCs invade and 
colonize ectopic sites (germinal ridges).  
Because embryonic stem cells (ESCs) are not recognized in adult tissue, they do not appear 
in Table 1. Neoplasm typically attributed to malignant malESCs, however, is cited in 
categories 2, 7, and 8. 
 
4.2.1 Cache cells (CC) and cancer cache cells (CCCs) 
The parenchyma of glandular organs (e.g., liver) is typically comprised of CCs. The cells 
“appear mitotically equivalent” (Rhim et al., 1994) and uniformly differentiated (but see 
Alison, 1998; König et al., 2005). The population is non-hierarchal and steady state. Cells are 
mono-potent, committed to their specific cell type. Their state of differentiation may change 
stochastically or gradually. In the liver, for example, CC differentiation regresses as cells 
move centripetally on septa.  
Cells are called “cache cells” because they constitute a “horde” of similar cells that can 
exceed normal rates of proliferation during regeneration the way a computer’s “cache 
memory” promptly retrieves data (Shostak, 2006). Previously, parenchymal cells, such as 
hepatocytes were dubbed “expanding” cells (Leblond, 1972), because nearly all of them 
undergo cell division during regeneration (e.g., induced by partial hepatectomy), and the 
population’s size expands virtually exponentially (Bucher & Swaffield, 1973). But at 
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Attached, epithelial-like, mono- oligo-potent: 
Steady state:  
Non-stem, symmetrical division, differentiated, non-hierarchal:  
 (1) Cache cells (CCs) and cancer cache cells (CCCs) 
CCs: superficially uniformly differentiated, mono-potent; CCCs: hepatoma carcinoma, angiosarcoma, 
(lymphangiosarcoma, or hemangiosarcoma), Kaposi sarcoma 
Stem, asymmetrical division, hierarchal populations:  
 (2) Organ stem cells (OSCs), cancer stem cells (CSCs), and malignant embryonic stem cells 
 (malESCs) 
OSCs: self-renewing, homogeneous, produce TACs: symmetrically dividing, clonally committed, 
terminally differentiating, limited potency; CSCs: expanding, metastatic, produce CTACs: 
adenocarcinomas, non-small cell lung cancer (NSCLC); malESCs: heterogeneous tumors differentiate 
in embryo-like patterns (melanoma, glioblastoma) 
Static state: 
Stem-like, induced asymmetrical division, hierarchal: 
 (3) Reserve and reserve cell-derived cancer cells  
Undifferentiated, arrested, retain ability to divide and differentiate, mono-potent; malignancies: 
rhabdomyosarcomas  
Unattached, amoeba-like, oligo- multi-potent: 
Steady state: 
Non-Stem, symmetrical division, non-hierarchal:  
 (4) Neoblasts  
Undifferentiated, cell division regulated by nutrition, multi-potent 
Static state: 
Non-Stem, stress (starvation) induced mitotic arrest, retain ability to divide, non-hierarchal: 
 (5) Stressed (regeneration or stockpile) cells 
Undifferentiated, stress induced mitotic arrest, may resume mitosis when stress is lifted (i.e., animals 
fed) 
Non-Stem, developmentally induced mitotic arrest, retain ability to divide, non-hierarchal: 
 (6) Quiescent cells and their derived cancer cells 
Differentiated, developmentally induced mitotic arrest (e.g., Hayflick limit); may be irretrievably 
arrested and nil-potent (C. elegans) or resume division conditionally and oligo-potent (vertebrates); 
malignancies: fibrosarcoma, synovialsarcoma 
Steady state 
Stem, asymmetrical division, hierarchal:  
 (7) Hematopoietic stem cells (HSCs), malignant HSCs (malHSCs); malignant ESCs (malESCs), 
 germ stem cells (GSCs) and malignant GSC (malGSCs) 
HSCs: heterogeneous, produce hematopoietic proliferative precursor (HPPs) and memory cells, multi-
potent; malHSCs (aka cancer initiating cells [CICs]), expanding metastatic malignant (malHPPs), 
leukemia, lymphomas; malESCs: small cell lung carcinoma; malGSCs: testicular and ovarian cancers 
Static state 
Stem-like, retain ability to divide, non-hierarchal: 
 (8) Mesenchyme (aka mesenchymal stem cells) and mesenchyme derived cancers (also malESCs) 
Unifferentiated (fibroblast-like), arrested, oligo- multi-potent, malignancies: chondrosarcomas, 
osteosarcomas, malignant fibrous histiocytoma, and liposarcoma 
 
Table 1. Classification of cell populations 
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The regeneration of CC populations would seem dependent on multiple controls. 
Regeneration in the liver, for example, tapers off when a normal mass is approximated 
irrespective of morphology, but a liver with its regenerative capacity exhausted by severe or 
chronic liver disease may yet regenerate as a function of proliferation by small stem-like 
oval cells in the intrahepatic bile ductules and (possibly) through the recruitment of extra-
hepatic stem cells from bone marrow (König et al., 2005).  
The mesothelium of the plural, pericardial, and peritoneal cavities, and the endothelium of 
vessels belong in the CC category, although endothelium is sometimes said to harbor stem 
cells (Potten et al., 1979). Endothelium may also consist of “mixed” CC and OSC-supported 
populations, and in glioblastoma, the presence of the same genomic alterations in a high 
percentage of endothelial cells and glioblastoma cells suggests that malignant neural cells 
transform into endothelium (Ricci-Vitiani et al., 2010; Wang et al., 2010) without cell fusion 
(Wurmser et al., 2004). The pancreatic parenchyma may also consist of “mixed” cell 
populations. Pancreatic islet cells divide symmetrically and thus qualify as CCs, although β 
pancreatic islet cells do not replace cells lost in type 1 diabetics (Dor et al., 2004). Pancreatic 
acini, on the other hand, harbor “multi-potent” stem cells with “a limited capacity for self 
renewal” (Weir & Bonner-Weir, 2004; Seaberg et al., 2004; Sangiorgi & Capecci, 2009; but see 
Brennand et al., 2007; Ku, 2008).  
Polyploidy (i.e., abnormal multiples of the chromosome number) and binuclearity (i.e., the 
presence of two nuclei in a cell) are widespread among CCs. These conditions do not 
represent adaptations to streamlining regeneration, since smaller mononuclear diploid cells 
provide most new cells during regeneration (Sigal et al., 1999). Polyploidy and binuclearity 
may represent accommodations to increasing metabolic demands, since cells with these 
traits accumulate with age, chronic stress, and oxidative injury (Goria et al., 2001). But nuclei 
of binuclear cells may also be evidence of degenerate change. When two nuclei fuse and 
divide symmetrically, they produce tetraploid cells (Guidotti et al., 2003), and “ploidy 
reversal” or “reductive mitoses” occurring despite bipolar spindles results in chromosomal 
imbalance and aneuploidy (Duncan et al., 2010) conducive of cancer (Ganem et al., 2009).  
CC populations may spawn symmetrically dividing cancer cache cells (CCCs). Endothelial 
CCCs, for example, are probably the source of angiosarcomas (lymphangiosarcoma, or 
hemangiosarcoma), and the spindle cells of Kaposi sarcoma may also be CCCs. 
Angiosarcomas and glioblastomas would seem to be composed of CCCs, but CCCs may 
become CSCs in “mixed” tumors consisting of CCC-like differentiated cells and 
undifferentiated CSC-like cells (e.g., polycythemia [myeloproliferative neoplasms]; Jepson, 
1969). 
Malignant hepatoma cells of hepatocellular carcinomas are archetypal CCCs. They divide 
symmetrically, rapidly and are sensitive to chemo and radiation therapy. Irradiated cells 
may be arrested at the G2/mitosis checkpoint if the DNA damage caused by radiation 
exceeds a threshold of two chromatid breaks or “a few” double-strand breaks (Ishikawa et 
al., 2010). Surprisingly, rat malignant hepatoma cells are oncogenic or not depending on 
their site of introduction and age of a host. Possibly, instead of a homogeneous CCC 
population, a heterogeneous population includes subsets able or not to establish themselves 
in different circumstances (McCullough et al., 1998).  
4.2.2 Organ stem cells (OSCs) and cancer stem cells (CSCs) 
OSCs exhibit self-renewal by asymmetric division. They are the classic label-retaining cells 
(LRC) thought to divide infrequently and frequently retain “immortal DNA” strands. In 
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contrast the TACs produced by OSCs divide rapidly and symmetrically producing clones of 
cells, typically with limited potency.  
OCSs occupy distinct niches where they undergo self-renewal (Li & Xie, 2005). Some niches 
are conspicuous such as the corneal limbus basal layer (Sun et al., 2010), the bulge of hair 
follicles (Clayton et al., 2007; Hsu et al., 2011), and the ends of intestinal glands between 
enteroendocrineocytes (Potten & Loeffler, 1990; Barker & Clevers, 2007). But some niches, 
such as the subventricular zone of the cerebral cortex and spinal cord (Lois & Alvarez-
Buylla, 1993; Weiss et al., 1996; Merkle et al., 2004; Maric et al., 2007; Doetsch et al., 2009) are 
only identified loosely as areas of asymmetric division (Lajtha, 1979; Tumbar et al., 2004) 
and might not truly qualify as niches, since the “simple location of stem cells is not sufficient 
to define a niche. The niche must have both anatomic and functional dimensions, 
specifically enabling stem cells to reproduce or self-renew” (Scadden, 2006). 
In the mammalian epidermis, self-renewal is constrained by the differential expression of β-
1 integrins and binding to the extracellular matrix (Lavker & Sun, 2000). The niche 
determines if TACs form hair follicles, hair, and sebaceous glands (Hsu et al., 2011) or if 
blocks of cells moving outward through the epidermis toward the surface synthesize a 
variety of keratins and finally differentiate as disposable squames (Blanpain & Fuchs, 2006). 
Epidermal cells occupying other niches produce fingernails, toenails, claws, and hooves. In 
the small intestine, basal glandular niches (Barker & Clevers, 2007; Fellous et al., 2009) 
produce TACs that divide and differentiate. Absorptive, dome (M), and goblet cells 
(Lelouard et al., 2001) move outward and are disposed of en masse at the intestinal surface. 
Parietal and chief cells, enteroendocrinocytes, and exocrinocytes stay in the gland until they 
are disposed of individually.  
Some astrocyte stem cells in the central nervous system (CNS) exhibit moderate 
oligopotency, since the products of their division differentiate as disposable neurons and 
glial cells (Quian et al., 2000; Doetsch, 2003; Walton et al., 2006). The CNS is derived from 
neuralectoderm, and, hence, from epithelium, but neuro/glioblasts produced by astrocyte 
stem cells are motile and amoeba-like, and the ependymal home of astrocytes (Weiss et al., 
1996) lacks a basal lamina and therefore does not qualify as an epithelium. 
Neuro/glioblasts, thus have taken on amoeboid characteristics after de-epithelializing. 
The relationship of OSCs to CSCs is ambiguous. Some solid tumors supported by CSCs 
share antigens with OSCs, and a stem subset among otherwise non-tumorigenic cells may 
express tumorigenicity (Bonnet & Dick, 1997; Al-Hajj et al., 2002; Hermann et al., 2007). 
CSCs do not necessarily arise in the same niches as those occupied by OSCs. For example, 
basal cell carcinoma arises in inter-follicular epidermis rather than the hair follicle’s bulge 
(Youssef et al., 2010). On the other hand, malignant stem cells, such as those of non-small 
cell lung cancer (NSCLC), an adenocarcinoma, may be derived in situ from bronchioalveolar 
OSCs following malignant transformation, and the CSCs of breast and colon cancers share 
affinities with OSCs.  
4.2.3 Reserve cells and cancers derived from reserve cells 
Reserve cells are undifferentiated dormant cells within a differentiated (typically, but not 
exclusively static) parenchyma derived from attached cells. Reserve cells include astrocytes 
(Rice et al., 2003; Martens et al., 2002) and pancreatic acinar cells (Sangiorgi & Capecci, 2009), 
but satellite cells (also known as quiescent myoblasts) in skeletal muscle are archetypal 
(Hawke & Garry, 2001). The satellite/skeletal muscle framework suggests that satellite cells 
are mammalian skeletal muscles stem cells held in mitotic abeyance. 
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Satellite cells reside within or beneath the external lamina of muscle fibers (in the 
sublaminal space or zone between the lamina and the sarcolemma of the muscle fiber) and 
are distributed evenly along the length of muscle fibers (with the exception of the 
neuromuscular junction). The sites occupied by satellite cells constitute a diffuse niche 
adapted to permit regeneration over the length of muscle fibers. During skeletal muscle 
regeneration, satellite cells become self-renewing, albeit briefly (Schultz, 1996) via 
asymmetric division. The stem cells exhibit differential “immortal DNA” strand retention, 
and the precursors of muscle fuse with sarcomeres and differentiate as skeletal muscle 
(Tajbakhsh et al., 2009).  
Reserve cells seem to have left the division cycle in the G1 post-mitotic gap. Following 
trauma, the proportions of satellite cells in S and G2 increase rather than drop-off 
demonstrating that cells have moved through the cycle (or that other cells have undergone 
apoptosis disproportionately; Relaix et al, 2006).  
Reserve cells are frequent suspects in the cancer lineup. Rhabdomyoblasts, or embryonic 
and fetal skeletal muscle cells appear in benign rhabdomyoma, in malignant 
rhabdosarcoma, embryonic, alveolar, and adult rhabdomyosarcomas. The precise etiology 
of rhabdomyoblasts is uncertain, but satellite cells may be their precursors (Merlino & 
Helman, 1999; Mercer et al., 2006).  
4.2.4 Neoblasts 
“Neoblast” is the generic term for dividing amoeboid cells in many well-fed, sponges, 
cnidarians, flatworms, and other protostomes. Neoblasts exhibit multi-potentiality during 
steady-state homeostasis, during regeneration, and somatic asexual reproduction, 
differentiating into a wide range of cells in the animal’s body. Hence, neoblasts are also 
called “stem cells” in the sense that they “branch” out and differentiate into a variety of non-
dividing cells, although they do not fulfill the additional stem-cell criterion of occupying a 
niche and representing a small slowly dividing part of a proliferative population. A 
distinguishing characteristic of neoblasts in flatworms and elsewhere is that cell division is 
down regulated by stress such as that brought on by starvation (Newmark & Alvarado, 
2000; Reddien & Alvarado, 2004).  
No malignant growths are attributed to neoblasts. Cell division in neoblasts seems to be 
held in check by homologues of the human p53 cancer suppressor gene which “functions in 
[planarian] stem cell proliferation control and self-renewal” (Pearson & Alvarado, 2010). 
 4.2.5 Stressed cells 
Stressed cells (aka regeneration or stockpile cells) in invertebrates are derived from 
neoblasts and similar cells after entering mitotic arrest typically induced by starvation 
(Hong et al., 1998). In flatworms, the rate of cell division in neoblasts declines to a “basic 
level” as a result of starvation (Nimeth et al., 2004). These stressed cells are arrested at the G2 
stage, presumably as an adaptation for a rapid return to mitosis. G2 arrested cells disappear 
following the resumption of feeding. The resulting highly plastic neoblasts then resume 
differentiating along multiple paths. In other animals, stressed cells may abandon the 
division cycle in G1. When arrest is persistent, these cells are identified as G0 or G1/G0 cells. 
No malignancies are attributed directly to stressed cells, although malignant cells may be 
“stressed.” 
In vertebrates, mitotically arrested cancer cells suffering from energy deficiencies due to a 
carbohydrate deficit might be considered stressed cells. Cancers acquire their energy largely 
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by glycolysis. Indeed, cancers’ demand for glucose, known as cancers’ “sweet tooth,” and 
the enhancement of glycolysis, known as the Warburg effect after Otto Warburg who 
discovered it in 1924, are dose dependent and correlated with the aggessivity of the 
malignancy in vivo (Elstrom et al., 2004). The Warburg effect leads to the excess production 
of lactate that induces several oncogenes, causes an acid environment protecting cancer cells 
from the immune system, and allows pyruvate to scavenge endemic hyperoxides. At the 
same time, reduced cofactors remove free radicals and relieve high oxidative stress created 
meeting demands of rapid cell division (Kim et al., 2009). The Warburg effect also explains 
why tumors light up in positron emission tomography (PET) with a glucose radioisotope 
(Garber, 2004) and suggests that cancers might be selectively starved with low carbohydrate, 
high fat or insulin-induced hypoglycemia/lactate supplemented therapeutic diets. 
Stress in mammals also triggers immuno-suppression that can be tumorigenic rather than 
therapeutic. For example, indirect deleterious effects of stress promote tumor development 
in rodents and human beings. Tumorigenesis under stress seems to result from immune 
suppression of natural killer cell activity (Ben-Eliyahu et al., 1999). For example, oxidative 
stress in myeloid cells makes them capable of inhibiting T-cell proliferation. The presence of 
oxidatively stressed cells “in a premetastatic niche … [may] help incoming tumor cells [i.e., 
CSCs] survive by inducing local immune suppression via inhibition of effector immune cells 
and by helping to evade immune system control, thus promoting metastasis growth” 
(Kusmartsev et al., 2008). 
4.2.6 Quiescent cells and cancers derived from quiescent cells 
Quiescent cells become mitotically dormant in the course of development (rather than as a 
consequence of stress). They are widespread in invertebrate adults. For example, in C. 
elegans, after adding cells throughout four larval stages, the hermaphrodite adult winds up 
with 959 quiescent somatic nuclei (1031 in males) arrested in G0/G1 (van den Heuvel, 2005).  
In vertebrates, quiescent cells are represented conspicuously by fibroblasts (aka fibrocytes). 
Arrested in G1, fibroblasts comprise numerous non-hierarchal, static state cell populations 
forming the bulk of stroma in organs including loose and dense, regular and irregular 
connective tissues. Osteocytes, chondrocytes, and possibly cardiac myocytes are also 
quiescent cells (Grounds et al., 2002).  
Remarkably, although fibroblasts are not ordinarily dividing, they support division in other 
cells. An underlying layer of irradiated, non-multiplying “feeder” fibroblasts in vitro 
sustains cell division in other cells (e.g., embryonic stem cells, epithelial, and cancer cells). 
“Feeder” fibroblasts are employed to “condition” tissue culture media thereby promoting 
cell division and aiding the establishment and upkeep of fragile cell lines (Puck et al., 1956). 
Fibroblasts can be provoked into division. They divide in the vicinity of wounds, in the 
uterine stroma during pregnancy, and in the breast during lactation. Dividing fibroblasts 
tend to remain fibroblasts although fibroblasts may be oligo-potent and differentiate into fat 
cells. And perichondral and periosteal fibroblasts also differentiate into cartilage and bone 
cells.  
Freshly explanted fibroblasts in tissue culture perform a large but limited number of 
divisions (e.g., 50–70) after which the cells enter a period of “mitotic quiescence” that may 
last months but is eventually followed by cell death. Known as the Hayflick limit after 
Leonard Hayflick who discovered it in the early 1960s, the number of divisions performed 
by freshly explanted fibroblasts in vitro is inversely proportional to the age of the organism 
from which the fibroblasts were taken (Hayflick & Moorhead, 1961; Kill & Shall, 1990). 
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Possibly, telomeric shortening is the “replicometer” determining cells’ Hayflick limit and 
mortality (Hayflick, 2000). The alleged “immortality” of transformed and cancer cells in 
vitro may be due to the over expression of telomerase and consequent maintenance of 
telomeres (Chan & Blackburn, 2002; Hackett & Creider, 2002; Shay et al., 2001). 
Fibroblasts produce benign leiomyomas (aka fibroids), malignant fibrosarcoma, and 
synovialsarcoma. Fibroblasts are not otherwise prone to malignancy (but see mesenchyme 
below). 
4.2.7 Hematopoietic stem cells (HSCs), malignant HSCs (malHSCs), germ stem cells 
(GSCs), and malignant GSC (malGSCs); malESCs (see 2 and 8) 
HSCs are the root stem cells of blood and lymphatic cells and all their derivatives both in 
circulation and sequestered in connective tissue. HSCs also sprout branches virtually 
everywhere: osteoclasts in bone, microglia in the central nervous system, dendritic cells in 
epithelia, and macrophages (e.g., histiocytes and dust cells) in lungs and elsewhere.  
Human HSCs are typically rhodamine 123 low and CD34 positive. HSCs, like their 
malignant counterpart, malHSCs, or “primitive HSCs” are typically heterogeneous with 
respect to rates of self-renewal and differentiation (Uchida et al., 1996; Hope et al., 2004). 
Cells range from rarely dividing stem-like cells to those on the verge of committed HPPs 
(Osawa et al., 1996).  
HSCs are highly multi-potent and HPPs widely competent, differentiating across a wide 
range of cell types. Even after reserving the title HSCs “for cells already committed to a 
hematopoietic phenotype” (Herzog et al., 2003), HSCs include common myeloid progenitors 
(CMPs), similar to cells in Drosophila that provide endothelial cells lining vessels in addition 
to blood cells (Owusu-Ansah & Banerjee, 2009), highly plastic bone marrow-derived stem 
cells (BMDSCs or BMSCs), and marrow stromal cells (MSCs aka mesenchymal stem cells) 
that produce clones differentiating into fat, cartilage, and bone (see Kode & Tanavde, 2010). 
HPPs include multi-potent adult progenitor cells (MAPCs), and prolific myelogenous blast 
cells that give rise to the multitude of circulating and fixed blood and lymphatic cells. And 
while the small lymphocyte seems genuinely non-dividing (Bekkum et al., 1971), medium 
and large proliferative lymphocytes in lymphopoietic organs, germinal zones, and nodules 
remain in contention for dividing T or B lymphocytes as well as cells playing a host of roles 
in immunity.  
HPPs can also become dormant “memory cells” (members of the B lymphocyte domain) that 
resume proliferation in response to unique antigens and growth factors (Ohta et al., 1998). 
Memory cells are way stations responsible for the secondary antibody response characteristic 
of acquired immunity and may function as “first responders” to new antigens.  
The plasticity of HSCs and malHSCs suggests that they are accessible to extensive 
reprogramming and expansion of potential in the process of forming clones. Reprogramming, 
if that is what it is, may also occur in malHPPs. For example, BMDSCs pass through a 
“metaplasia/dysplasia/carcinoma progression” into adenocarcinoma of the stomachs of 
C57BL/6 mice chronically infected with Helicobacter pylori (Houghton et al., 2004). 
Moreover, BMDSCs form stromal myofibroblasts in esophageal adenocarcinoma including 
epithelial tumor cells and endothelial cells (possibly) following fusion with host cells 
(Hutchinson et al., 2010).  
The production of malHSCs may also be determined by conditions rather than an inherent 
commitment to this particular fate. For example, “primitive” HSCs that become the 
malHSCs of leukemia/lymphoma stem cells (LSCs) over express the cancer inducing bcl-2 
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oncogene in the presence of serum containing the KIT ligand (also known as the steel factor 
cytokine or stem cell factor [SCF]) and undergo stimulated cell division at the onset of 
malignant differentiation.(Domenet al., 1998; Domen & Weissman, 2000).  
MalHSCs or LSCs also seem to be members of a heterogeneous population of cells differing 
in rates of self-renewal and degrees of commitment (e.g., in AML; Hope et al., 2004). LSCs 
seem to be common, since “more than 10% of cells in many mouse leukemia and 
lymphomas are transplantable” (Adams et al., 2007). In fact, AML cells in mice are easily 
transplanted to nonirradiated histocompatible (congenic) recipient mice (Kelly et al., 2007; 
Adams & Strasser, 2008) leaving the impression that bulk AML cells rather than stem cells 
as such are capable of propagating the malignancy. 
The germ line fits the HSC mold. The adult male germ line beyond dormant spermatogonia 
is easily placed in this category of stem cells. Even dormant spermatogonia (Clermont, 1962) 
can be placed in the stem-cell category allowing that they mimic reserve cells. And the adult 
female germ line of mammals, once thought to be static, is now conceded to be stem. GSCs 
in the ovarian surface epithelium (OSE or germinal epithelium) produce primary follicles in 
vitro and in vivo while in contact with underlying connective tissue (Johnson et al., 2004; 
Bukovsky et al., 2005).  
Germ line niches such as the basal compartment of seminiferous tubules (Lin, 1998; De Rooij 
& Grootegoed, 1998) may exert “extrinsic” influences on asymmetric divisions, but 
“intrinsic” cellular influences also affect the geometry of chromosomal delivery and the 
“unequal distribution of key regulators” (Kim & Hirth, 2009). In the Drosophila ovary, the 
position of oogonia near the end of terminal filaments seems to depend on the expression of 
the piwi gene that suppresses GSC differentiation while promoting self-renewal (Lin, 1997). 
Further down the filament, the oriented asymmetrical division of GSCs creates the 
cystoblast or germ-line cyst that gives rise to “assembly line organization, with each egg 
chamber representing a differentiated stem cell product whose position along the ovariole 
corresponds to its birth order” (Cox et al., 1998).  
Remarkably, in Drosophila, asymmetric division in mutant GSCs takes place in the absence of 
the centrosome. “[C]entrosoms are not required for the proper orientation of the spindle 
relative to the … niche in female GSCs,” but centriole orientation is essential for 
embryogenesis (Stevens et al., 2007), and spindle mis-orientation consequent to mutations 
may contribute to tumorigenesis. The activities of “tumour suppressors, lgl, dig and scrib, in 
controlling the asymmetric segregation of cell-fate determinants in larval neuroblast … 
[suggest] that impaired cell-fate determination itself could cause tumour growth” 
(Gonzalez, 2007). 
MalGSCs are the presumptive cause of malignant testicular and ovarian cancers (Lin, 1997). 
Evidence linking malGSCs to GSCs is weak, but the nuclei of spermatogonia bear 
“cancer/testis” antigens (e.g., Brdt, SSX, NY-ESO-1, members of the melanoma antigen and 
SPANX families; MacLean & Wilkinson, 2005). (For malESCs see 4.2.2 and 4.2.8.) 
4.2.8 Mesenchyme (aka mesenchymal stem cells [MSCs]) and cancers derived from 
mesenchyme 
Mesenchyme is defined classically as the highly hydrated connective tissue of embryos 
(Shostak, 1991), but the drier adult connective tissue of bone, skeletal muscle, dermis, and 
heart are often said to contain mesenchyme (see Kode & Tanavde, 2010). The appellation 
“mesenchyme” is also attached to pericytes, contractile cells sharing the basal lamella with 
endothelium in capillaries and small venules. In addition, MSCs are frequently equated with 
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HSC-derivatives, marrow stromal cells (also MSCs), BMDSCs, and MAPCs. In effect, 
“mesenchyme” in adults is a synonym for a subset of generally quiescent fibroblasts readily 
mobilized for mitosis by growth factors. Mesenchymal cells are not known to be self-
renewing and are not confined to a recognized niche, but they may otherwise resemble 
reserve fibroblasts. Alternatively, mesenchyme may be compared to a normally slowly 
dividing CC-like population but especially active in regeneration.  
Mesenchyme’s relationship to embryonic connective tissue must not be taken too literally or 
dismissed too lightly. Wnt genes link malignant mesenchyme to embryonic signal 
pathways. In malignant fibrous histiocytoma (aka high-grade undifferentiated pleomorphic 
sarcoma) expressing the DKK1 gene, the gene’s protein, Dkk1, is an inhibitor of the Wnt 
developmental program. Inhibiting Wnt2 signaling in human MSCs or their progenitor cell 
products transforms them into malignant fibrous histiocytoma-like tumor cells following 
injection into immuno-compromised mice. Amazingly, reestablishing Wnt signaling in 
malignant fibrous histiocytoma returns the cells to their normal connective tissue status 
(Matushansky et al., 2007). Regrettably, Dkk1 does not perform the same trick in 
carcinomas. 
Mesenchyme may also be a source of malESCs responsible for malignancies of soft tissue, in 
particular, following the malignant transformation of perivascular “mesenchymal” cells 
(Iwasake et al., 1987). Malignant chondrosarcomas and osteosarcomas may also have 
mesenchymal etiologies as may malignant fibrous histiocytoma and liposarcoma.  
5. Evolution of normal and cancer cell populations 
“Chance and necessity” (Monod, 1971) are the motors that drive evolution over the rocky 
road of Darwinian competition and selection. Multicellular animals have been on that road a 
long time and chance and necessity have had ample opportunity to work their magic on the 
tissues and cancers of animals. Epithelial cell populations would have the most ancient roots 
if attached cells evolved from biofilms and biomats (recently reassigned to the pre-
Phanerozoic; Arp et al., 2001; Bengston et al., 2009). Newly discovered fossils of epithelial-
like organisms clock in at 2.1 billion years before the present (El Albani et al., 2010). 
Amoeboid cells have ancient roots too if not quite as ancient as epithelia. Acritarchs 
associated with marine algae suggest that unicellular eukaryotes were around somewhere 
between the late Paleoproterozoic and Early Mesoproterozoic epochs, 1.6–1.3 billion years 
before the present (Knoll et al., 2006).  
Competition between these life forms inevitably drove them into conflict, and a form of 
conflict resolution known as “escape toward” would have driven epithelia and amoeba into 
symbiotic relationships. Presumably, somewhere, some time, or, more likely, in many places 
and many times symbiotic relationships were attempted and an occasional one proved 
successful. Evolution’s creative powers were then unleashed especially when “Life got big” 
(Narbonne, 2011) in the wake of fluctuating levels of free oxygen in the post-glacial early 
Ediacara (Yuan et al., 2011).  
Today, the placozoan, Trichoplax adhaerens (Grell & Ruthmann, 1991) may be the last 
surviving purely epithelial metazoan, while vast numbers of amoeboid organisms testify to 
the continued viability of the amoeboid way of life. Competition and selection in 
epithelial/amoeba symbiotic organisms, however, proved more innovative and inventive, 
and led to the enormous diversity of tissues and organs found across the multicellular 
animal kingdom.  
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5.1 Evolution of cell populations and tumors with epithelial lineages  
The evolution of epithelial-derived cell populations turns out to track increasingly 
sophisticated controls over cell division during the production of increasingly complex 
tissues. Solid tumors compete with epithelia and their derivatives largely by defeating 
controls over cell division while accommodating to tissue complexity. 
The origins of an epidermis can be found in freshwater sponges (Demospongiae, 
Haplosclerida). Surface pinacocytes form an epithelium exhibiting close intercellular 
junctions that resist permeability and the diffusion of small-molecules while offering high 
transepithelial electrical resistance and a transepithelial potential. Pinacocytes retain these 
properties during regeneration and asexual reproduction and are not transformed into other 
types of cells (Adams et al., 2010).  
In Hydra (Cnidaria, Hydrozoa), the epithelial epidermis and gastrodermis are composed of 
cache-like cell populations. In the epidermis, potency is limited to surface epithelium, 
battery cells, and possibly nerve and gland cells in the foot, while in the gastrodermis, 
potency is limited to digestive cells and possibly some digestive gland cells. The rate of cell 
division in these epithelia is a function of the availability of food (Shostak, 1979, 1982). 
Sustenance levels of feeding support the production of cells in sufficient quantities for 
maintenance (homeostasis) and regeneration. Feeding above sustenance levels supports 
growth, and further feeding supports asexual reproduction as well (Campbell, 1967a, 1967b; 
Shostak, 1968, 1974). Restraints on the growth of epithelia appear in some anthozoans (e.g., 
anemones), however, where body size and asexual reproduction are constrained (Shick & 
Hoffmann, 1980).  
Regulation of growth increases in Platyhelminthese and Aschelminthes. Flatworms have a 
quiescent cellular epidermis (Rieger et al., 1991), and in adult round worms, with the 
exception of smaller species that retain a small number of cells, the subcuticular “epidermis” 
is a syncytium with quiescent nuclei plus a row of quiescent lateral line seam cells (Wright, 
1991). The mere presence of multiple nuclei within a unified cytoplasm is not the 
explanation for mitotic dormancy, since nuclei in plasmodia such as those of insect eggs and 
the true slime mold, Physarum, divide abundantly. Rather, the absence of mitosis in syncytia 
would seem an adaptation for inhibiting growth.  
Growth is also constrained internally as an accommodation to an unyielding integument or 
exoskeleton in animals where complexity militates against removing excess cells via asexual 
reproduction. The regulation of growth within the organism would also seem to have been a 
prerequisite for the evolution of complex internal organs (Extavour et al., 2005), and curbs 
on cell division seem to have ratcheted up with the complexity of parenchymal 
differentiation. In contemporary vertebrates, cells that have left their niches in embryos, 
such as sensory and motor neurons and skeletal muscle do not divide at all. Mitosis seems 
to have been curbed entirely in the course of evolution of highly differentiated cell 
populations where growth would be disruptive.  
Other tissues adopted the steady state to meet size constraints without sacrificing the 
flexibility inherent in cellular replacement. CC populations epitomize steady-state cell 
populations, losing and gaining cells at the same rate in dynamic equilibrium. OSC 
populations then branched off CC populations when cell division was further restricted in a 
self-renewing population separated from the bulk of dividing TACs (Stanger et al., 2007). In 
OSC-supported populations, asymmetric cell division is confined to cells that remain in 
their niche following division. Reserve (satellite) cells evolved from OSCs by the further 
restriction of cell division to the point of arrest in G1 “until needed.” 
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Epithelial-derived tissues seem to have invested heavily over the course of their evolution in 
preventing oncogenic mutations. Thus, “the G2/M checkpoint is invariably activated in 
cancer cells in response to DNA damage” (Wang et al., 2009). In G2 arrested cells, entry to 
mitosis is blocked when Cdc25 phosphatases fail to remove the inhibitory phosphorylation 
of (inactivated) complexes of mitotic CDK, Cdc2 (aka Cdk1) and B-type cyclins. Moreover, 
the chief regulator of the G1/S checkpoint is the tumor-suppressor p53 gene whose products 
also prevent the expression of NANOG and other embryonic stem cell factors associated 
with malignancy (Zbinden et al., 2010). The widespread retention of the “immortal strand” 
of DNA by OSCs and satellite cells would also seem an anti-mutation adaptation. The 
presence of label-retaining cells (LRCs) in breast and intestinal cancers (Trosko, 2006; Bussard 
et al., 2010b; Barker et al., 2008) suggests that these tumors’ CSCs are derived from OSCs.  
On the other hand, the cells of solid tumors seem to have devised mechanisms for 
competing successfully with the cells of normal solid organs. CCCs override the rules 
governing steady state dynamics in CC populations, and CSCs may have branched off OSCs 
by violating the terms of stem-cell regulation. “Mixed” cancers containing stem and non-
stem cells (e.g., pancreatic cancer and myeloproliferative neoplasm) suggest that CCCs may 
also step-up to CSCs with increased malignancy. Thus, CCCs are equipped with two deadly 
weapons, the step-up to CSC and the epithelial-to-mesenchymal transitions (EMT) (Prindull 
& Zipori, 2004). With these weapons, tumor cell populations not only undermine the 
restraints imposed by cell-to-cell communication, but they escape the limits imposed by 
asymmetric division. Malignant cells increase in number, break out of their niche, and 
overpower normal defenses (Powell et al., 2010; Quyn et al., 2010). 
Some solid tumors seem to begin as pure accidents. For example, cancers develop following 
“chromosome missegregation” of “lagging chromosomes” in damaged aneuploid 
hepatocytes (Ganem et al., 2009). And other epithelial cancers may be initiated, promoted, or 
progress through the accumulation of breaks, translocations, and errors of replication that 
prevent tumor suppressor genes from completing DNA repair, create aberrant products in 
signaling pathways, or permit the notorious EMT (see Ansieau et al., 2008). Genetic and 
epigenetic changes in some solid tumors suspend normal terminal differentiation and 
disposal, turning rapidly dividing TACs into malignant CACS. These malignancies are hotly 
pursued under the rubric of targeted therapy (Gilbert & Ross, 2009). For example, the 
Wnt/β-catenin, Hedgehog, and Notch signal transduction pathways of cell division are also 
pathways of differentiation and offer especially vulnerable points for therapeutic attack 
(Taipale & Beachy, 2001). In addition, these pathways are associated with tumor 
suppressors, such as PTEN (Stambolic et al., 1998) suggesting still other opportunities for 
therapeutic intervention.  
5.2 Evolution of cell populations, leukemia, lymphomas, germ, and soft tissue 
cancers with amoeboid lineages 
Amoeba-like cells are the obvious choice for ancestors of neoblasts, for unattached cells, and 
for freely moving cells including germ-line cells in multicellular animals. Contemporary 
amoebas even behave much like neoblasts and like scavenger blood cells in today’s 
multicellular animals. “Interestingly … environmental cues such as temperature, starvation, 
and high population are potent inducers of autophagy in yeast, Dictyostelium and mammals 
… [as well as] dauer formation in C. elegans” (see below; Meléndez & Levine, 2009). 
Presumably, stress provokes ancient mechanisms in these cells’ adaptive repertoire 
including the suspension of cell division.  
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Many amoebas cease dividing following starvation but resume cell division after turning to 
cannibalism. Similarly, large amoeboid cells or archeocytes in sponges (Porifera) acquire 
reserves by cannibalizing adjacent trophocytes in response to seasonal adversity and produce 
an encapsulated gemmule. When growth conditions return, the gemmule “hatches.” Cells 
stream through the capsule’s micropyle and commence cell division and morphogenesis.  
Amoebas also exhibit multi-potentiality. For example, amoebas of the cellular slime mold 
(aka social amoeba), Dictyostellium discoideum, attracted by cyclic adenosine monophosphate 
(cAMP) to its source, congregate and differentiate into distinctively contrasting cells of slug 
and fruiting body (see Bonner, 1988; Margulis et al., 1990). Likewise, in freshwater sponges, 
multi-potential amoebocytes emerging from reduction bodies differentiate as choanocytes as 
well as various types of amoebocytes (Bisbee et al., 1989). In general, sponge amoeboid cells 
contribute to growth, maintenance, asexual reproduction, and regeneration by generating a 
variety of cells: fiber cells or desmocytes, muscle or myocytes, spongin-producing 
sponbioblasts, food-containing trophocytes, pigmented chromocytes, large archaeocytes, 
gland, and germ cells (Hanson, 1977). 
In Cnidaria, amoeboid cells or interstitial cells produce as many as seven types of cnidocysts 
(average 3 per species; Shostak & Kolluri, 1995) as well as sensory and motor neurons, 
several types of gland cells (Hwang et al., 2007), and germ cells (Littlefield, 1985, 1991). 
Amoeboid cells also fill regression bodies in response to adversity, undergo multi-potent 
differentiation during regeneration (Shostak, 2005), and participate in asexual reproduction 
through budding, regenerative fragmentation, strobilation, and fission (Shostak, 1993).  
In well-fed flatworms, multi-potential neoblasts proliferate and differentiate (Newmark & 
Alvarado, 2000). By replacing effete cells, neoblasts maintain specialized organs, the 
epidermis enclosing the animal, the gastrodermis lining its gut, and the “fixed” 
parenchymal cells between these epithelial layers. Neoblasts also aid in remodeling the 
animal during regeneration and reconstituting it during asexual reproduction (Pellettieri et 
al., 2010). In starving animals, neoblasts become dormant stressed cells but return to the 
neoblast status upon the resumption of feeding.  
Likewise, larvae of the celebrated round worm, C. elegans, respond to stress by “conditional 
cell cycle arrest” (Hong et al., 1998). Thus stressed newly hatched, L1 larvae cease 
developing and enter the dauer diapause. Stressed cells remain in mitotic suspension 
indefinitely, prolonging the life of the larva (hence dauer), but, when conditions permit, the 
cells return to mitotic cycling, and development resumes (Meléndez & Levine, 2009) along 
determined lines of differentiation (Sulston et al., 1983).  
Amoeba-like cells left a long evolutionary line of descendants in vertebrates from connective 
tissue to germ with blood and lymph cells prominently in the middle. HSCs and malHSCs 
are enormously plastic and spawn a variety of blood, lymphatic, and connective tissue cell 
types, normal and malignant. Their version of “stemness” has unique features. HSCs and 
malHSCs appear outside their niche in circulation. Recruitment or self-seeding is also 
characteristic of these stem cell. Thus HSCs repopulate organs (e.g., bone marrow, lymph 
nodes, and thymus) depleted by disease or radiation, while the arrival of circulating 
malHSCs (aka cancer initiating cells [CICs]) at sites of metastasis and the further recruitment 
of circulating malHSCs or malHPPs would seem at least partially responsible for the growth 
of leukemia/lymphomas (Zon, 2008). Recruitment might also be a point of attack for 
intervention. Leukemia/lymphomas might be kept from growth and brought back to the 
steady state by recreating the “environmental guidance” that prevents recruitment 
(McCulloch, 1983).  
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Fibroblasts of connective tissue seem to have adopted quiescence as a way of restraining 
growth, although cell division may still be an option as it is in so-called mesenchyme. 
Benign growths of fibroblasts do not compare with malignant sarcomas presumably of 
mesenchymal origin.  
Both male and female germ lines clearly evolved from amoeboid cells as witness the 
extensive intercellular bridges present in pre-germ cells (see Shostak, 1991), while the 
“pseudopods” on the outer lamellae of male gonocytes would seem perfect reminiscences of 
amoeba. On the other hand, the epithelial-like zona pellucida (i.e., an extracellular 
membrane) surrounding mature mammalian eggs would seem a harbinger of 
epithelialization of the future blastocyst. 
5.3 Evolution of cell populations with malignant embryonic cell lineages 
Because the rates of cell division in some tumors, leukemia, and lymphomas actually 
approach exponential growth (see Shibata & Kern, 2007-8), cancers are sometimes said to 
represent the release of arrested embryonic cells (Sell, 2008) or a transformation of adult 
cells to an embryonic state (Weinberg, 1996). But high rates of cell division are also found in 
normal adult OSCs. Mouse intestinal OSCs, for example, divide once a day (Barker & 
Clevers, 2007). The appearance of an abundance of dividing cells in cancers (Norton, 2007-8; 
Tomasetti & Levy, 2010) may also be exaggerated as a consequence of stem cell recruitment 
(Zon, 2008). 
Attributing cancers to anything resembling ESCs is all the more difficult, since normally, 
there are no ESCs in adults. ESCs that appear briefly in the mammalian blastocyst’s inner 
cell mass and embryonic plate exist afterwards only in tissue culture or briefly following re-
introduction into blastocysts.  
Normally, in amniotic vertebrates, and conspicuously in placental mammals, the first wave 
of embryonic cells is diverted from embryogenesis toward establishing maternal contact. As 
the blastocyt implants in the uterus, massive numbers of small cells become motile. Strictly 
and irretrievably determined, these cells migrate beneath the chorion, fill out chorionic villi, 
and form the rudiments of a maternal/embryonic exchange system. Gradually, other 
embryonic plate cells, no longer ESCs, accumulate and fall under local and global 
commands directing them into germ layers, endo-, ecto-, and mesoderm. Subsequently, 
endoderm folds into the foregut; endo-mesoderm vesicles converge into the heart-forming 
region; dermo-myotomes and the neural crest de-epithelialize, and motile cells are released; 
gonocytes occupy the germinal ridges, and hemocytoblasts colonize liver and bone marrow 
(see Shostak, 1991). The local and global forces controlling these activities are so powerful 
that they can even bring small numbers of cancer cells, such as those of teratocarcinomas, 
into line and direct them toward normal pathways of differentiation in all germ layers 
(Minsk & Illmensi, 1976). 
The possibility that latent ESCs continue in adults seems remote in light of their virtual 
absence in germ layers and differentiating tissues, but ESCs are sometimes thought to be 
represented by OSCs, HSCs, and GSCs, and these latent ESCs are even said to be the sources 
of malESCs. Thus, the notorious EMT is thought to be reminiscent of de-epithelialization in 
embryonic tissue releasing motile invasive cells. This possibility would seem especially apt 
for melanomas, malignant schwannomas (neurolemmacytomas) and malignant peripheral 
nerve sheath tumors (neurofibrosarccomas or triton tumors), all bearing putative ESC 
markers while resembling retarded embryonic cells differentiating along neural crest lines. 
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Other malignant cells said to be malESCs are small cells (typically smaller than a red blood 
cell but larger than a platelet; see Konala et al., 2010), as well as very small embryonic-like 
stem cells (VSEL-SCs) or small embryonic-like stem cells (SELSCs) expressing “early stem 
cell markers” such as CXCR4 and CD4, and “signature ESC genes” such as NANOG, a 
member of the HEDGEHOG-GLI signaling cascade, CD133 (Zbinden et al., 2010), Oct-4, and 
SSEA-4 (see Zuba-Surma et al., 2010; Sharma & Krishan, 2010). Like embryonic cells, the 
small malignant cells are multi-potent, differentiating into a variety of tumors from 
“pediatric sarcomas (e.g., rhabdomyosarcoma, neuroblastoma, Ewing-sarcoma Wilm’s 
tumor) … [to adult] malignancies (e.g., stomach cancer)” (see Kucia et al., 2007). The most 
aggressive of these are probably small cell lung carcinoma (SCLC aka oat-cell carcinoma) 
and small-cell carcinomas appearing, if rarely, in the prostate and cervix (Mooi, 2001). 
A difference in the number of mutations in two cancers (i.e., in their “mutational burden”) 
provides the best evidence, if only suggestive, for a unique type of cancer cell, albeit not 
necessarily a malESC. The mutational burden for small-cell lung cancer (Pleasance et al., 
2010) is only about half that of a non-small cell lung cancer (Lee et al., 2010). The difference 
does not seem to be due to mechanisms of mutation or efforts the cells make to correct 
errors in their DNA, since the frequencies of predominant changes in DNA, such as 
transversion of G C T A→i i , are similar in both tumors, as are genomic rearrangements and 
gene translocations. Furthermore, mutation rates in the transcribed strands of DNA are 
lower than in the non-transcribed strands in both cancers. The different mutational burdens, 
therefore, would seem due to the small cell lung cancer’s cells having accumulated 
mutations over a shorter period of time than the non-small cell lung cancer’s cells. 
Conceivably, ES-like small cells residing in a dormant state would not accumulate as many 
mutations as non-small adult cells dividing regularly.  
6. Conclusions 
The present search for the ancestral branch and root of cancers’ stem cells began by testing 
the merits of opposing hypotheses: A rudimentary stem cell is the ancestor of cancers’ stem 
cells; the stem cells of different cancers evolved in different ancestral cell populations. The 
first hypothesis proposes that “self-renewal” unifies stem cells, while the second hypothesis 
proposes that cancers’ different stem cells are unrelated.  
Unexpectedly, the first hypothesis founders on irreconcilable differences among stem cells. 
Above all, OSCs and CSCs turn out to be label-retaining cells (LRCs), while HSCs and 
malHSCs are not (or not demonstrably). Thus, OSCs and CSCs preserve “immortal strands” 
of DNA and/or divide sluggishly, while HSCs and malHSCs do not preserve “immortal 
strands” and/or divide comparatively rapidly. What is more, while asymmetrical division 
occurs in both normal stem cells supporting steady-state populations and reserve cells 
supporting static cell populations, CSCs and malHSCs have added symmetric division to 
their modes of cell division (or have fallen back on embryonic habits) while exhibiting the 
malignant phenotype. In addition, HSCs and malHSCs are vastly more plastic than OSCs 
and CSCs, and the fate of clones and the disposal of products of terminal differentiation are 
also different. Thus, “stemness” is different in OSCs and CSCs, on one hand, and HSCs and 
malHSCs on the other, and stem cells cannot be brought under the umbrella of a unifying 
concept. The notion of a rudimentary stem cell giving rise to all stem cells must, therefore, 
be abandoned as without foundation.  
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Which leaves the possibility that the stem cells of different cancers arose through 
competition in cell populations. The similarities of CSCs to OSCs in their stem, steady state, 
attached cubbyhole, and of malHSCs to HSCs in their stem, steady state, unattached 
cubbyhole fit expectations, but the presence of malignancies in six of the eight categories of 
cell populations, including non-stem cells (Table 1), suggests that cancer/normal 
competition went well beyond stem populations. In each of these six categories, the cancer 
and normal cells have more in common with each other than they have with cells in other 
categories suggesting that each of these cancer and normal cell pairs arose in a common 
cell-population ancestor and adopted their normal and malignant phenotypes by 
competition.  
Genomic evidence suggests, moreover, that the evolution of cancers in cell populations is 
ongoing (Notta et al., 2011; Anderson et al., 2011). For example, competition seems to have 
trimmed differences between lymphoblastic leukemia and breast cancer cells. Their 
“transcriptomes” (all the RNA produced in a cell population) or gene expression profiles 
(demonstrated through laser capture micro-dissection and DNA microarrays) display 
“extensive similarities” from initiation through progression (Ma et al., 2003) and from 
original masses to remote metastases (Weigelt et al., 2003). Furthermore, evolution is at 
work among genetically distinct lymphoblastic leukemia cells. These branch out into multi-
clonal cancers, and, in lymphoblastic leukemia, the competitive regenerative capacity of 
cells growing in immuno-compromised mice (and the prognosis for patients from whom the 
cells were derived) changes with the tumors’ genetic profile.  
Of course, the old-fashioned Darwinian methodology employed here cannot say definitively 
if competition within cell populations gave rise to normal and malignant stem cells, but the 
evolutionary scenario sketched out here provides a model for future testing. According to 
this scenario, the evolution of animal cell populations began in symbiotes of epithelial and 
amoeboid cells in the pre-Phanerozoic. Initially, cell growth was indeterminate, subject only 
to the availability of resources. Excess cells were simply relegated to propagules of asexual 
reproduction. But restraints on cell division evolved in response to limitations imposed by 
animal size. Cellular quiescence or dormancy evolved in animals of small size and brief 
lifespan and in sequestered tissues, while the steady state evolved in long-lived, large 
animals and in tissues meeting size constraints while producing new cells in response to 
stress and contingency. A limiting scaffold determined the number of cells permitted in the 
steady state population while cell division was permitted to fill gaps. 
More subtle controls were required to accommodate turnover in steady state cell 
populations sustaining cell loss in the process of meeting normal functional demands. Stem 
cells evolved when niches replaced the scaffold supporting steady state cell populations, 
and asymmetric division permitted the retention of one out of every two cells produced by 
division. Epithelial-derived stem cell populations placed a higher priority on controlling cell 
division than amoeboid-derived stem cells, it would seem, because attached cells are under 
greater pressure to conform to size limitations than freely moving cells. Thus, steady state 
CC populations evolved into stem-cell populations when cell division in self-renewing 
OSCs was constrained by the requirement to divide sluggishly while retaining the 
“immortal strand” of DNA. Cell division in “primitive” HSCs was not as greatly restrained 
in evolving self-renewing HSCs presumably due to the ease of disposing of excess cells.  
Ultimately, cell populations produced the animals’ tissues and organs. CC and OSC 
populations became organismal surface layers, the substance (parenchyma) of organs, 
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nerve, smooth muscle, and skeletal muscle equipped with reserve cells. Motile amoeba-like 
cells became amoeboid archeocytes, interstitial cells, neoblasts, stressed cells, the quiescent 
cells of connective tissues, and (probably) cardiac myocytes. HSCs’ precursors also gave rise 
to mesenchyme and germ cells, and hemocytoblasts evolved in animals with mesothelial-
lined cavities (Hartenstein, 2006). Epithelial and amoeboid characteristics also mixed, for 
example, as eggs epithelialized by oriented spindles, and amoeboid cells emerged from 
germ layers by de-epithelialization.  
Likewise, cancers evolved through similar competition and selection in six of the eight 
categories of cell populations. And like their normal counterparts, cancers also mixed 
epithelial and amoeboid characteristics. For example, metastatic sites collect free cancer-
initiating cells (CICs) and produce carcinomas, while the epithelial-to-mesenchymal 
transition (EMT) creates metastatic, invasive, and destructive amoeba-like cells from 
carcinomas.  
As always, evolution is a push and pull process. Inclusive fitness has deployed successful 
strategies for neutralizing cancers in most animals. For example, small animals that 
discharge excess cells in reproductive propagules are not troubled by cancers, and other 
small animals having turned off growth in adult soma are preadapted to “cancer free” life. 
This option is not available for large animals, such as human beings, obliged to maintain cell 
replacement in steady state cell populations at homeostasis, but large animals are not bereft 
of alternative defenses against cancers. For example, inclusive fitness, it would seem, 
pushed most human cancers into the time of life beyond the prime reproductive years, and 
we are also well equipped with massive systemic defenses, such as the immuno-surveillance 
system. Of course, cancers evolved countermeasures such as recruiting stromal barriers to 
macrophages, and evolution exapted some cancers with a buffer of slowly dividing stem 
cells providing stubborn resistance to the best efforts at chemo- and radiotherapy. 
Ultimately, competing evolutionary forces may resolve conflict and reach a detente. Thus, 
some (ancient?) malignant and normal cell populations would seem to have reached 
equilibrium (e.g., adenomas derived from CCCs) and many cancers are all but unknown 
except when induced by radiation, carcinogens, etc. On the other hand, highly malignant 
cancers (e.g., melanomas and small cell lung cancers) are far from equilibrium and may be 
newly evolving or easily provoked by conditions of contemporary life.  
In sum, Dobzhansky has been vindicated, and the light of evolution brightens the outlook 
for making sense of cancer. Most importantly, researchers equipped with an evolutionary 
perspective may now be able to devise effective strategies for preventing cancers, detecting 
them early, and bringing those cancers that cannot be prevented into equilibrium with 
normal tissues. 
Obviously, cancer’s should not be given a competitive edge through exposure to 
anthropogenic carcinogens such as those in cigarette smoke, air pollutants, the polynuclear 
aromatic hydrocarbons, chlorinated hydrocarbons, pesticides, and/or metals in effluvia and 
food. Researchers should seek clues for prevention in the prophylactic devices deployed 
against cancers by most animals and our own young. Researchers hoping to detect, monitor, 
and track cancers should also take a hard look at perturbations in the biometrics of normal 
tissues competing with neoplasm rather than relying solely on the detection of cancer’s 
markers. Finally, by correcting cancers’ equation of state for competition and selection, 
cancers’ evolution in the past should be plotted and steps taken to thwart the flow of 
cancers’ evolution in the future.  
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